HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 218.36 billion as of May 14, 2026. Its market cap has decreased by -19.51% in one year.

Market Cap

218.36B

Enterprise Value

216.90B

Revenue

205.58B

Ranking

n/a

PE Ratio

111.07

Stock Price

14,740.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 218.36B, an increase of 159.09%. That is a compound annual growth rate of 9.59%.

Market Cap History

Date	Market Cap	% Change
May 13, 2026	218.36B	-3.05%
Dec 30, 2025	225.24B	-33.44%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BNC KOREA	244.51B
Boditech Med	228.07B
CMG Pharmaceutical	223.69B
Chong Kun Dang Holdings	221.13B
Samjin Pharmaceuticals	218.68B
Hyundai Pharmaceutical	217.27B
Whan In Pharm	211.09B
Daewon Pharmaceutical	209.19B

Market Cap Rankings